Ischemic Preconditioning Attenuates Renal Ischemia-Reperfusion Injury by Inhibiting Activation of IKKβ and Inflammatory Response

被引:36
|
作者
Chen, Xin [2 ]
Liu, Xiaodong [1 ]
Wan, Xin [1 ]
Wu, Yu [1 ]
Chen, Yu [1 ]
Cao, Changchun [1 ]
机构
[1] Nanjing Med Univ, Nanjing Hosp 1, Dept Nephrol, Nanjing 210006, Peoples R China
[2] Nanjing Med Univ, Nanjing Hosp 1, Dept Chest Surg, Nanjing 210006, Peoples R China
基金
中国国家自然科学基金;
关键词
Acute kidney ischemia; Ischemia preconditioning; I kappaB kinase beta (IKK beta); Neutrophil gelatinase-associated lipocalin (NGAL); NF-KAPPA-B; GELATINASE-ASSOCIATED LIPOCALIN; ACUTE KIDNEY INJURY; EARLY URINARY BIOMARKER; PROTEIN-KINASE-C; EXPRESSION; PROTECTION; ARF;
D O I
10.1159/000225928
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Renal ischemia-reperfusion (I/R) injury is a major cause of acute renal failure (ARF). The transcription factor nuclear factor-kappa B (NF-kappa B) has been implicated as a key mediator of reperfusion injury. Activation of NF-kappa B is dependent upon the phosphorylation of its inhibitor, I kappa B, by the specific inhibitory kappa B kinase (IKK) subunit, IKK beta. We hypothesized that ischemic preconditioning (IPC) reduces acute renal damage following I/R injury by inhibiting activation of IKK beta. As neutrophil gelatinase-associated lipocalin (NGAL), an early predictive biomarker of acute kidney injury, is regulated by NF-kappa B, we approached the relationship between NGAL and IKK beta. Method: Thirty male Sprague-Dawley rats were randomly divided into 3 groups after right kidney nephrectomy. Group A rats were sham-operated controls. Group B rats were 45-min ischemic in the left renal artery while Group C rats were pre-treated with 3 cycles of 2-min ischemia and 5-min reperfusion. All the rats were sacrificed at 24 h after reperfusion. We harvested kidneys and serum to do further analysis, including histological and functional parameters, expressions of NGAL and IKK beta in renal tissues. Results: Compared with rats subjected to I/R injury, pretreated rats had a significant decrease in serum creatinine level (Scr) and tubulointerstitial injury scores (Scr, 86.79 +/- 12.98 vs. 205.89 +/- 19.16 mu mol/l, p<0.01; tubulointerstitial injury scores, 1.3 +/- 0.48 vs. 3.8 +/- 0.79, p<0.01). In addition, expressions of IKK beta (0.95 +/- 0.21 vs. 1.74 +/- 0.17, p< 0.05) and NGAL (1.71 +/- 0.032 vs. 2.66 +/- 0.078, p<0.05) at renal tubule in pre-treated rats were attenuated significantly compared with rats subjected to ischemia-reperfusion injury. Moreover, our study showed that IKK beta and NGAL were in positive correlation (R=0.965>R-0.01(30) = 0.448, p<0.01). Conclusions: The evidence suggests that IKK beta may play a role in renal I/R injury and give rise to the generation of NGAL. It appears that IPC may attenuate renal injury and the expression of NGAL following acute I/R injury. IKK beta may offer a clinically accessible target for preventing renal injury following I/R. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:287 / U127
页数:8
相关论文
共 50 条
  • [1] Osthole Ameliorates Renal Ischemia-Reperfusion Injury by Inhibiting Inflammatory Response
    Zheng, Yi
    Lu, Min
    Ma, Lulin
    Zhang, Shudong
    Qiu, Min
    Ma, Xin
    UROLOGIA INTERNATIONALIS, 2013, 91 (03) : 350 - 356
  • [2] Renal ischemia-reperfusion injury attenuated by splenic ischemic preconditioning
    Shen, Y.
    Olu, T.
    Liu, X. -H.
    Zhang, L.
    Wang, Z. -S.
    Zhou, J. -O.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (07) : 2134 - 2142
  • [3] Delayed Ischemic Preconditioning Attenuated Renal Ischemia-Reperfusion Injury by Inhibiting Dendritic Cell Maturation
    Zhang, Ting
    Song, Nana
    Fang, Yi
    Teng, Jie
    Xu, XiaLian
    Hu, Jiachang
    Zhang, Pan
    Chen, Rongyi
    Lu, Zhihui
    Yu, Xiaofang
    Ding, Xiaoqiang
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 46 (05) : 1807 - 1820
  • [4] Mangiferin attenuates renal ischemia-reperfusion injury by inhibiting inflammation and inducing adenosine production
    Wang Bin
    Wan Jingyuan
    Gong Xia
    Kuang Ge
    Cheng Xiahong
    Min Su
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 25 (01) : 148 - 154
  • [5] The optimal duration of ischemic preconditioning for renal ischemia-reperfusion injury in mice
    Choi, Hyun Su
    Hwang, Jeong Kye
    Kim, Jeong Goo
    Hwang, Hyeon Seok
    Lee, Sang Ju
    Chang, Yoon Kyung
    Kim, Ji Ii
    Moon, In Sung
    ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2017, 93 (04) : 209 - 216
  • [6] Autophagy activation attenuates renal ischemia-reperfusion injury in rats
    Zhang, Ya-Li
    Zhang, Jie
    Cui, Li-Yan
    Yang, Shuo
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2015, 240 (12) : 1590 - 1598
  • [7] Effects of remote ischemic preconditioning and topical hypothermia in renal ischemia-reperfusion injury in rats
    Motta, Guilherme Lang
    Souza, Pablo Cambeses
    dos Santos, Emanuel Burck
    Bona, Silvia Regina
    Schaefer, Pedro Guilherme
    Torres Lima, Caetano Araujo
    Possa Marroni, Norma Anair
    Corso, Carlos Otavio
    ACTA CIRURGICA BRASILEIRA, 2018, 33 (05) : 396 - 407
  • [8] Which remote ischemic preconditioning protocol is favorable in renal ischemia-reperfusion injury in the rat?
    Varga, Gabor
    Ghanem, Souleiman
    Szabo, Balazs
    Nagy, Kitti
    Pal, Noemi
    Tanczos, Bence
    Somogyi, Viktoria
    Barath, Barbara
    Deak, Adam
    Matolay, Orsolya
    Bidiga, Laszlo
    Peto, Katalin
    Nemeth, Norbert
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2020, 76 (03) : 439 - 451
  • [9] Sympathetic nervous response to ischemia-reperfusion injury in humans is altered with remote ischemic preconditioning
    Lambert, Elisabeth A.
    Thomas, Colleen J.
    Hemmes, Robyn
    Eikelis, Nina
    Pathak, Atul
    Schlaich, Markus P.
    Lambert, Gavin W.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2016, 311 (02): : H364 - H370
  • [10] Nanoselenium attenuates renal ischemia-reperfusion injury in rats
    Sadeghmanesh, Farzaneh
    Eidi, Akram
    Mortazavi, Pejman
    Oryan, Shahrbanoo
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2024, 397 (04) : 2297 - 2310